Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Yasmin vs Diane-35 on Metabolomics in PCOS
NCT04831151Unknown
- Sponsor
- Inonu University
- Start
- Mar 2021
- Primary completion
- Mar 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial in polycystic ovary syndrome (PCOS) comparing Drospirenone Group with Cyproterone Acetate Group (2 arms). Primary endpoint: Blood Metabolomics at 3 months. Status: unknown.
02
Drugs
drospirenoneethinyl estradiol + cyproterone
03
Conditions
polycystic ovary syndrome (PCOS)
Beyond the preview
Go deeper on NCT04831151.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04831151.